#USA #Chicago #FDA Clearance #Sysmex America #CN-6000

Sysmex America Receives FDA Clearance for CN-6000™ Automated Blood Coagulation Analyzer

In a significant advancement for diagnostic solutions, Sysmex America, Inc. has announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for its state-of-the-art CN-6000 Automated Blood Coagulation Analyzer. This new system includes a suite of reagent products necessary for conducting five essential hemostatic tests that are commonly performed in laboratories.

Enhancing Hemostasis Testing with Innovative Technology

The CN-6000™ is designed to address the increasing demand for efficient and reliable blood coagulation testing. It particularly focuses on five critical tests, including Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), and others using trusted reagents such as Dade® Innovin® and INNOVANCE®. These tests are vital in diagnosing patients who suffer from bleeding or clotting disorders, and Sysmex's integrated approach combines advanced technology with award-winning customer service, delivering dependable results to healthcare providers.

According to Sysmex America’s CEO, Dan Zortman, “Our hemostasis solutions bring together advanced technology, trusted reagents, and award-winning service to provide laboratories with reliable results for diagnosing patients suffering from bleeding or clotting disorders.”

Key Features of the CN-6000™ System

One of the standout features of the CN-6000™ is its high throughput capacity. The fully automated system is compact, making it suitable for laboratories with limited space, and it offers expandability to accommodate varying workload demands. For laboratories dealing with high volumes of tests, an optional sampler is available to increase sample loading capabilities. This innovative design not only saves space but also enhances the efficiency of lab operations.

Future Developments and Continued Innovation

Sysmex America is committed to advancing its product offerings and will continue its efforts to secure market authorization for additional systems, including the CN-3000 and more reagent applications. This ongoing innovation is crucial in the ever-evolving landscape of healthcare, where the need for precise diagnostic tools is paramount.

To learn more about the CN-6000 and other cutting-edge hemostasis products, visitors can explore the company's official website at sysmex.com.

About Sysmex America

Sysmex America is the regional affiliate of Sysmex Corporation, headquartered in Kobe, Japan. Renowned for its contributions to hematology, hemostasis, urinalysis, flow cytometry, and informatic systems, Sysmex America is transforming healthcare by equipping laboratory professionals with advanced diagnostic solutions. The company’s commitment to innovation is recognized, as it was recently named one of the most innovative companies in the healthcare equipment and services sector by Forbes.

Sysmex America remains dedicated to fostering healthier lives and enhancing the operational efficiency of clinical laboratories through reliable and effective diagnostic products. Their ongoing mission aligns with the overarching goal of improving patient care and outcomes across various healthcare settings.